Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
‘£30 for a ready meal ?!’ Do Charlie Bigham’s new dishes really beat going to a restaurant ?
18/10/2025
‘A 360 turn’ : concern as fashion shows feature fewer plus-size models
17/10/2025
Your Guardian sport weekend : Premier League returns, F1 in the US and World Cup cricket
17/10/2025
Oggy oggy oggy ! The donk-tacular dance music of Hull’s huge funfair
17/10/2025
Keeper review – a sparkling ecological fantasia of pure imagination
17/10/2025
Tell us your favourite TV romcom of all time
17/10/2025